Heyman Richard A.

CIK 000158475910 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001584759

Recent Transactions

50 trades

Sale
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2026-07-06$12.00/sh−300→ 212,772 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-02-17$26.18/sh−1,230→ 22,647 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-02-12+19,234→ 19,234 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-20$26.46/sh−512→ 24,595 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-20$26.96/sh−718→ 23,877 total
Sale
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2026-01-16$12.00/sh−3,500→ 41,800 total
Sale
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2026-01-16$12.00/sh−3,200→ 213,072 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-09$25.00/sh−4,285→ 25,107 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-08$25.04/sh−8,015→ 29,392 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-08$25.00/sh−1,620→ 25,545 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2026-01-02+40,000→ 40,000 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-10-03−13,228→ 33,700 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2025-10-03$3.75/sh+1,447→ 45,300 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Common Stock
2025-10-03$1.60/sh+31,353→ 43,853 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-10-03−1,447→ 52,253 total
Exercise/Conversion
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-10-03−18,125→ 0 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2025-06-05+33,500→ 33,500 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+23,014→ 23,014 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2025-01-02+35,000→ 35,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-18$30.00/sh−753→ 27,165 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-18$30.00/sh−817→ 123,673 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-15$27.67/sh−1,270→ 124,490 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-04$27.51/sh−2,825→ 125,760 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-01$27.54/sh−518→ 128,585 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-09-16$22.41/sh−1,270→ 129,103 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-08-15$23.70/sh−620→ 130,373 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-08-15$22.82/sh−650→ 130,993 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-31$27.50/sh−649→ 27,918 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-31$27.51/sh−1,702→ 131,643 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-15$24.80/sh−1,270→ 133,345 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-06-17$21.48/sh−1,270→ 134,615 total
Award
Oric Pharmaceuticals, Inc.$ORIC
Stock Option (right to buy)
2024-06-12+25,600→ 25,600 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2024-06-06+67,500→ 67,500 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-16$23.74/sh−1,270→ 135,885 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-15$20.68/sh−80→ 137,155 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-15$19.94/sh−1,190→ 137,235 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$25.03/sh−5,045→ 138.425 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$25.00/sh−649→ 28,567 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-03-19$14.50/sh−1,270→ 143,470 total
Disposition to Issuer
RayzeBio, Inc.
Common Stock
2024-02-26$62.50/sh−367,446→ 0 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-02-15$17.42/sh−1,270→ 144,740 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-02-13+29,205→ 29,205 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-02-13+21,043→ 21,043 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-01-30$16.41/sh−1,270→ 146,010 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2023-12-22$13.00/sh−35→ 29,216 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2023-12-22$13.00/sh−168→ 147,280 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2023-12-21$13.00/sh−7→ 147,448 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2023-12-21$13.00/sh−6→ 29,251 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2023-12-20$13.02/sh−2,110→ 147,455 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2023-12-20$13.02/sh−1,915→ 29,257 total

Heyman Richard A.

Recent Transactions

Companies

Recent Filings

Address